Davis Polk is pleased to host a series of webinars over the coming months focused on legal considerations for life sciences companies. In this first installment, senior members of the Dav...
This client update highlights some considerations for the preparation of your 2022 annual report on Form 20-F. As in previous years, we discuss both disclosure developments and continued ...
On June 23rd, the staff of the SEC’s Division of Corporation Finance issued new Disclosure Guidance Topic No. 9A reflecting the staff’s current views regarding disclosure that compani...
With the end of the first quarter upon us, we’ve put together some practical tips and recommendations for those working on public company first quarter reporting in light of the impact ...
Many of our clients are taking a close look at their sources and uses of cash over the next several quarters and beyond in the face of a potentially prolonged period of market and busines...
As part of the SEC’s continuing effort to streamline disclosure for smaller companies, the Securities and Exchange Commission announced on June 28 that it had adopted a final rule to re...
